Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

Company Performance - Viking Therapeutics, Inc. (VKTX) closed at $67.10, reflecting a +0.55% change from the previous day's closing price, outperforming the S&P 500's gain of 0.13% [1] - The company's shares increased by 17.67% over the past month, significantly surpassing the Medical sector's gain of 3.34% and the S&P 500's gain of 3.67% [1] Earnings Forecast - The upcoming earnings release is anticipated, with a forecasted EPS of -$0.24, indicating a 4.35% decline compared to the same quarter last year [2] Analyst Estimates - Recent changes to analyst estimates for Viking Therapeutics are noteworthy, as positive revisions are generally seen as a favorable indicator for the company's business outlook [3] - The Zacks Rank system, which reflects these estimate changes, provides actionable insights for investors [4] Zacks Rank and Industry Performance - Viking Therapeutics currently holds a Zacks Rank of 3 (Hold), with a 0.99% decrease in the Zacks Consensus EPS estimate over the past month [5] - The Medical - Biomedical and Genetics industry, which includes Viking Therapeutics, has a Zacks Industry Rank of 83, placing it in the top 33% of over 250 industries, indicating strong performance potential [6]